Namrata Saroj
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Namrata Saroj is the founder of Clinical Trials Resource Group, founded in 2019.
Current jobs include Chief Business Officer at Ocular Therapeutix, Inc. since 2024 and President at Association For Macular Diseases.
Former job includes Executive Director at Regeneron Pharmaceuticals, Inc. Education includes undergraduate and doctorate degrees from the University of California, Berkeley, and an undergraduate degree from Whittier College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/01/2026 | 254 620 ( 0,12% ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | 01/02/2024 |
Association For Macular Diseases
Association For Macular Diseases Miscellaneous Commercial ServicesCommercial Services The Association For Macular Diseases, operating as the American Macular Degeneration Foundation (AMDF), is a 501(c)(3) non-profit organization focused on preventing, treating, and curing macular degeneration, including age-related macular degeneration (AMD) and Stargardt disease. The private company is located in the US. AMDF provides educational content about macular degeneration types, symptoms, causes, risk factors, diagnosis, and treatment options such as anti-VEGF drugs, gene therapy, stem cell treatments, and artificial retina technology. The foundation emphasizes early detection, lifestyle modifications, and nutrition to support retinal health, and offers resources like low vision aids, assistive technologies, emotional and caregiver support, legal guidance, and cooking shows for eye health. AMDF engages the community through patient stories, educational videos, newsletters, and advocacy, and funds scientific research through grants for studies on biological pathways, biomarkers, and new treatments. | President | - |
| Sociétés | Poste | Fin |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whittier College
Whittier College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association For Macular Diseases
Association For Macular Diseases Miscellaneous Commercial ServicesCommercial Services The Association For Macular Diseases, operating as the American Macular Degeneration Foundation (AMDF), is a 501(c)(3) non-profit organization focused on preventing, treating, and curing macular degeneration, including age-related macular degeneration (AMD) and Stargardt disease. The private company is located in the US. AMDF provides educational content about macular degeneration types, symptoms, causes, risk factors, diagnosis, and treatment options such as anti-VEGF drugs, gene therapy, stem cell treatments, and artificial retina technology. The foundation emphasizes early detection, lifestyle modifications, and nutrition to support retinal health, and offers resources like low vision aids, assistive technologies, emotional and caregiver support, legal guidance, and cooking shows for eye health. AMDF engages the community through patient stories, educational videos, newsletters, and advocacy, and funds scientific research through grants for studies on biological pathways, biomarkers, and new treatments. | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national